Brand  (β version)

  The number of atoms exceeds 100,000.
  So, it can not be displayed here.

Select unit:

Select hetatm:   

close
information
centroid:
interaction residue:

Select chain:   Sequence  

Data format:   

Color scheme of protein:

Ligands
Code Name Style Show Link
F48 3-[5-(3-cyclohexyl-3,5,8,10-tetrazatricyclo[7.3.0.0^{2,6}]dodeca-1(9),2(6),4,7,11-pentaen-4-yl)furan-2-yl]propanenitrile
PHU 1-phenylurea
EDO 1,2-ethanediol
Non-standard Residues
Code Name Show
Glycosylation
Code Name Emphasize
Modification
Code Name Show
Code : 6GLB   PDBj   RCSB PDB   PDBe
Header : TRANSFERASE
Title : Crystal structure of JAK3 in complex with Compound 20 (FM484)
Release Data : 2018-06-27
Compound :
mol_id molecule chains synonym
1 Tyrosine-protein kinase JAK3 A,B Janus kinase 3,JAK-3,Leukocyte janus kinase,L-JAK
ec: 2.7.10.2
Source :
mol_id organism_scientific organism_common expression_system
1 Homo sapiens  (taxid:9606) Human Spodoptera frugiperda  (taxid:7108)
gene: JAK3
expression_system_vector_type: bacmid
Authors : Chaikuad, A., Forster, M., von Delft, F., Edwards, A.M., Arrowsmith, C.H., Bountra, C., Laufer, S.A., Knapp, S., Structural Genomics Consortium (SGC)
Keywords : KINASE, JAK3, COVALENT INHIBITOR, REVERSIBLE COVALENT INHIBITOR, INDUCED POCKET, ARGININE POCKET, STRUCTURAL GENOMICS CONSORTIUM, SGC, TRANSFERASE
Exp. method : X-RAY DIFFRACTION ( 2.00 Å )
Citation :

Development, Optimization, and Structure-Activity Relationships of Covalent-Reversible JAK3 Inhibitors Based on a Tricyclic Imidazo[5,4- d]pyrrolo[2,3- b]pyridine Scaffold.

Forster, M.,Chaikuad, A.,Dimitrov, T.  et al.
(2018)  J. Med. Chem.  61 : 5350 - 5366

PubMed: 29852068
DOI: 10.1021/acs.jmedchem.8b00571

Chain : A, B
UniProt : P52333 (JAK3_HUMAN)
Reaction: EC: Evidence:
Physiological Direction:
ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl- [protein] 2.7.10.2 PROSITE-ProRule:PRU10028
-